Annual Report 2024

29 Share participation plans

Share-based payments charged to personnel expenses

millions of CHF

 

2024

 

2023

Restricted share unit plan

 

1.4

 

0.5

Performance share plan

 

2.9

 

2.1

Total charged to personnel expenses

 

4.4

 

2.5

Restricted share unit plan settled in medmix shares

This long-term incentive plan covers the Board of Directors and certain new management members as a replacement for forfeited, unpaid and unvested performance and/or retention bonus payments and awards with previous employers. Restricted share units (RSUs) are granted annually to the Board of Directors and at the joining date of certain new management members. The plan features graded vesting over a one-year, two-year, or three-year period. One RSU award is settled with one medmix share at the end of the vesting period. The fair value of the RSUs granted is measured at the grant date closing share price of medmix Ltd, adjusted by expected dividends during the vesting period. Participants are not entitled to dividends declared during the vesting period. Consequently, the grant date fair value of the RSUs is reduced by the present value of the dividends expected to be paid during the vesting period.

Restricted share units for the Board of Directors

Grant year

 

2024

 

2023

 

2022

 

2021

 

Total

Outstanding as of January 1, 2023

 

 

 

16’797

 

1’830

 

18’627

Granted

 

 

25’153

 

 

 

25’153

Exercised

 

 

 

–5’600

 

–915

 

–6’515

Forfeited

 

 

 

 

 

Outstanding as of December 31, 2023

 

 

25’153

 

11’197

 

915

 

37’265

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of January 1, 2024

 

 

25’153

 

11’197

 

915

 

37’265

Granted

 

34’577

 

 

 

 

34’577

Exercised

 

–399

 

–12’250

 

–7’788

 

–915

 

–21’352

Forfeited

 

–3’425

 

 

 

 

–3’425

Outstanding as of December 31, 2024

 

30’753

 

12’903

 

3’409

 

 

47’065

 

 

 

 

 

 

 

 

 

 

 

Average fair value at grant date in CHF

 

15.02

 

20.65

 

32.08

 

43.92

 

-

Restricted share units for new management members

Grant year

 

2024

 

2023

 

Total

Outstanding as of January 1, 2023

 

 

 

Granted

 

 

20’421

 

20’421

Exercised

 

 

–2’413

 

–2’413

Outstanding as of December 31, 2023

 

 

18’008

 

18’008

 

 

 

 

 

 

 

Outstanding as of January 1, 2024

 

 

18’008

 

18’008

Granted

 

123’206

 

 

123’206

Exercised

 

 

–8’261

 

–8’261

Outstanding as of December 31, 2024

 

123’206

 

9’747

 

132’953

 

 

 

 

 

 

 

Average fair value at grant date in CHF

 

15.82

 

17.96

 

-

Performance share plan settled in medmix shares

This long-term incentive plan covers the members of the Executive Committee and other selected individuals employed in defined roles. Performance share units (PSU) are granted annually, depending on the organizational position of the employee.

Vesting of the PSP is based on the achievement of three pre-determined performance conditions:

The number of vested PSUs is determined by multiplying the number of originally granted PSUs by the total achievement factor, rounded up to the next full number of vested PSUs. For each vested PSU, one medmix share will be transferred to the individual plan participant on the share delivery date.

The following inputs were used to determine the fair value of the PSUs at grant date using a Monte Carlo simulation:

Grant year

 

2024

 

2023

 

2022

Fair value at grant date

 

15.11

 

22.64

 

31.81

Share price at grant date

 

16.40

 

17.85

 

32.90

Expected volatility

 

36.00%

 

35.26%

 

36.83%

Risk-free interest rate

 

1.03%

 

1.96%

 

0.39%

The expected volatility of the medmix shares is determined by the historical volatility. The zero-yield curve from Switzerland was used as the relevant risk-free rate. Historical data was used to arrive at an estimate for the correlation between medmix and the Swiss Performance Index.

Performance share units – terms of awards

Grant year

 

2024

 

2023

 

2022

Number of awards granted

 

209’222

 

169’832

 

127’194

Grant date

 

April 01, 2024

 

April 01, 2023

 

April 01, 2022

Performance period

 

01/24–12/26

 

01/23–12/25

 

01/22–12/24

Fair value at grant date in CHF

 

15.11

 

22.64

 

31.81

Performance share units

Grant year

 

2024

 

2023

 

2022

Outstanding as of January 1, 2023

 

 

 

123’651

Granted

 

 

169’832

 

Exercised

 

 

–240

 

–4’258

Forfeited

 

 

–2’002

 

–7’704

Outstanding as of December 31, 2023

 

 

167’590

 

111’689

 

 

 

 

 

 

 

Outstanding as of January 1, 2024

 

 

167’590

 

111’689

Granted

 

209’222

 

 

Exercised

 

–660

 

–3’132

 

–2’015

Forfeited

 

–5’745

 

–16’481

 

–10’044

Outstanding as of December 31, 2024

 

202’817

 

147’977

 

99’630